Everolimus Eluting Coronary Stent System
- UID
- MFG/MD/2022/000680_c87d460d00d3564b32bb8aea8cee3662_13a273a39e57074aef610bd8ab250a9c
- Device class
- Class D
- Brand name
- Eternia-AB
- License holder
- Innvolution Healthcare Pvt. Ltd.
- Approving authority
- CDSCO -North Zone, Ghaziabad
- Product information
- Everolimus Eluting Coronary Stent system (Eternia-AB) is intended for use in the patient eligible for Percutaneous Transluminal Coronary Angioplasty (Eternia-AB). Everolimus Eluting Coronary Stent System is indicated for improving coronary luminal diameter in patients with symptomatic ischemic disease due to discrete de novo lesions of length less than equal to 48 mm in native coronary arteries with a reference vessel diameter of 2.00 to 4.50 mm
Everolimus Eluting Coronary Stent System is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2022/000680_c87d460d00d3564b32bb8aea8cee3662_13a273a39e57074aef610bd8ab250a9c. This device is marketed under the brand name Eternia-AB. The license holder is Innvolution Healthcare Pvt. Ltd., and it is classified as Device Class Class D. The approving authority is CDSCO -North Zone, Ghaziabad.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.